Teva Pharm to buy Mexican drug firm Rimsa for $2.3 bln

TEL AVIV, Oct 1 (Reuters) - Teva Pharmaceutical Industries has agreed to acquire Representaciones e Investigaciones Médicas SA (Rimsa), a leading drugmaker in Mexico, for $2.3 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.